European Heart Journal-Cardiovascular Pharmacotherapy

ISSN: 2055-6837• JCR: EUR HEART J-CARD PHA• Oxford University Press• United Kingdom
Visit Journal Homepage
6.1
2025 Impact Factor
5.6
5-Year Impact Factor
Q1
JCR Quartile
B1
CAS Block

European Heart Journal-Cardiovascular Pharmacotherapy impact factor and JCR quartile

The 2025 impact factor for European Heart Journal-Cardiovascular Pharmacotherapy is 6.1. The 5-year impact factor is 5.6. The journal is listed as JCR Q1 in the current Journal Metrics dataset.

Use this record to check the journal title, ISSN, JCR quartile, CAS block, publisher details, and similar journals before comparing publication venues.

Journal Details

Total Articles
921
H-Index
58
Open Access
Hybrid
APC
$3,895 USD
Subject Areas
Cardiology and Cardiovascular MedicineCardiology and Cardiovascular MedicineCardiology and Cardiovascular MedicineInternal MedicineSurgery

Article Volume

2021
89
2022
71
2023
100
2024
97
2025
98
2026
17

Similar Journals

Europace
ISSN: 1099-5129
7.4Q1
Bone & Joint Journal
ISSN: 2049-4394
4.6Q1
JACC-Clinical Electrophysiology
ISSN: 2405-500X
7.7Q1
European Journal of Heart Failure
ISSN: 1388-9842
10.8Q1
Heart Rhythm
ISSN: 1547-5271
5.7Q1
Heart Failure Reviews
ISSN: 1382-4147
4.2Q1

Related Guides

Publishing Guide
How to Choose the Right Journal for Your Research Paper
15 min read
Publishing Guide
Journal Selection Criteria: Essential Factors for Choosing the Right Publication Venue
20 min read
Publishing Safety
How to Verify Journal Indexing: Scopus, Web of Science, PubMed, DOAJ, and More
18 min read
Impact Factor Basics
Understanding JCR Quartiles: Q1, Q2, Q3, Q4 Explained
12 min read
Back to Search